Minerva Neurosciences, Inc. (NERV)
2.32
+0.08
(+3.57%)
USD |
NASDAQ |
Oct 30, 16:00
2.30
-0.02
(-0.86%)
After-Hours: 20:00
Minerva Neurosciences Net Income (Quarterly) : 17.47M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 17.47M |
| March 31, 2026 | -125.40M |
| December 31, 2025 | -283.67M |
| September 30, 2025 | -2.744M |
| June 30, 2025 | -3.259M |
| March 31, 2025 | -3.753M |
| December 31, 2024 | -4.272M |
| September 30, 2024 | 22.51M |
| June 30, 2024 | -8.234M |
| March 31, 2024 | -8.569M |
| December 31, 2023 | -9.022M |
| September 30, 2023 | -7.820M |
| June 30, 2023 | -6.192M |
| March 31, 2023 | -6.970M |
| December 31, 2022 | -6.726M |
| September 30, 2022 | -6.900M |
| June 30, 2022 | -8.718M |
| March 31, 2022 | -9.764M |
| December 31, 2021 | -21.31M |
| September 30, 2021 | -9.205M |
| June 30, 2021 | -10.59M |
| March 31, 2021 | -8.805M |
| December 31, 2020 | -7.325M |
| September 30, 2020 | -8.113M |
| June 30, 2020 | 29.53M |
| Date | Value |
|---|---|
| March 31, 2020 | -12.15M |
| December 31, 2019 | -29.92M |
| September 30, 2019 | -13.96M |
| June 30, 2019 | -12.48M |
| March 31, 2019 | -15.83M |
| December 31, 2018 | -13.20M |
| September 30, 2018 | -12.02M |
| June 30, 2018 | -12.53M |
| March 31, 2018 | -12.42M |
| December 31, 2017 | 0.162M |
| September 30, 2017 | -11.26M |
| June 30, 2017 | -9.780M |
| March 31, 2017 | -10.64M |
| December 31, 2016 | -9.404M |
| September 30, 2016 | -8.423M |
| June 30, 2016 | -5.214M |
| March 31, 2016 | -8.004M |
| December 31, 2015 | -8.439M |
| September 30, 2015 | -5.939M |
| June 30, 2015 | -6.610M |
| March 31, 2015 | -6.093M |
| December 31, 2014 | -7.442M |
| September 30, 2014 | -27.16M |
| June 30, 2014 | -19.37M |
| March 31, 2014 | -2.938M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Heron Therapeutics, Inc. | -5.489M |
| Tonix Pharmaceuticals Holding Corp. | -40.55M |
| Karyopharm Therapeutics, Inc. | -67.02M |
| Corbus Pharmaceuticals Holdings, Inc. | -35.04M |
| Ocugen, Inc. | -24.88M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | -17.47M |
| EPS Diluted (Quarterly) | -0.1379 |
| Enterprise Value | 105.94M |
| Earnings Yield | -1.24K% |
| Normalized Earnings Yield | -422.06 |